Please login to the form below

Not currently logged in
Email:
Password:

HIV vaccine

This page shows the latest HIV vaccine news and features for those working in and with pharma, biotech and healthcare.

Gates’ non-profit biotech for poverty diseases sets out its stall at BIO

Gates’ non-profit biotech for poverty diseases sets out its stall at BIO

The targets of its programmes are still being identified, but include the development of an effective TB vaccine to prevent infections, and universal drug regimen for those already infected with the ... Previously, Heaton served as director of the

Latest news

  • Janssen’s quest to prevent diseases taking hold Janssen’s quest to prevent diseases taking hold

    Janssen’s acquisition of Crucell in 2011 brought it a suite of promising platforms covering HIV, a universal flu vaccine, respiratory syncytial virus (RSV), which is an infection of the lungs ... This potent test bed has helped with development of its

  • GSK’s pipeline cull claims sirukumab, and possibly rare disease unit GSK’s pipeline cull claims sirukumab, and possibly rare disease unit

    The company has spread its R&D spend too thinly in the past, and needs to focus on a smaller number of therapeutic categories - HIV and respiratory plus oncology and ... Over the next three years the critical new products for GSK will be its closed

  • Efficacy trials get underway for HIV vaccine in South Africa Efficacy trials get underway for HIV vaccine in South Africa

    Efficacy trials get underway for HIV vaccine in South Africa. Study hopes to provide partial immunity against the virus. ... Researchers are testing an HIV vaccine in efficacy trials for the first time in seven years in the hope that the candidate will

  • Bionor gears up for 'kick and kill' HIV data Bionor gears up for 'kick and kill' HIV data

    Norwegian biotech Bionor is just weeks away from completing a clinical trial to gauge the effectiveness of its therapeutic vaccine for HIV. ... an opportunity to see whether the 'kick and kill' theory of HIV therapy may achieve a cure.

  • HIV vaccine from J&J starts human trials HIV vaccine from J&J starts human trials

    HIV vaccine from J&J starts human trials. Vaccine provided complete protection in primates for similar infection . ... Scarcity of funding is also threatening a Russian HIV vaccine candidate called CombiHIVvac, which is heading for phase II testing.

More from news
Approximately 1 fully matching, plus 26 partially matching documents found.

Latest appointments

  • Aelix Therapeutics appoints Dr Thomas Hecht Aelix Therapeutics appoints Dr Thomas Hecht

    its HIV vaccine. ... After decades of work to develop a HIV vaccine, I hope to contribute with my experience in building a strong player that I believe has good chances to be amongst the

  • Sanofi appoints NIH’s Gary Nabel as chief scientific officer Sanofi appoints NIH’s Gary Nabel as chief scientific officer

    Sanofi appoints NIH’ s Gary Nabel as chief scientific officer. He previously headed vaccine research centre of the US National Institute of Allergy and Infectious Diseases. ... During this period, he provided overall direction of the VRC, including the

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics